Christina Rossi
Directeur des opérations chez BLUEPRINT MEDICINES CORPORATION
Fortune : 3 M $ au 31/05/2024
Postes actifs de Christina Rossi
Sociétés | Poste | Début | Fin |
---|---|---|---|
BLUEPRINT MEDICINES CORPORATION | Directeur des opérations | 04/04/2022 | - |
Corporate Officer/Principal | 29/10/2018 | 04/04/2022 | |
XILIO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/04/2021 | - |
Independent Dir/Board Member | 01/04/2021 | - |
Historique de carrière de Christina Rossi
Anciens postes connus de Christina Rossi
Sociétés | Poste | Début | Fin |
---|---|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2012 | 01/10/2018 |
Eidetica Biopharma GmbH
Eidetica Biopharma GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Eidetica Biopharma GmbH is a Swiss company that develops and manufactures biopharmaceutical drugs. The company is based in Zug, Switzerland. | Corporate Officer/Principal | 01/01/2005 | 01/01/2010 |
Formation de Christina Rossi
Duke University | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 6 |
Suisse | 2 |
Opérationnelle
Corporate Officer/Principal | 3 |
Chief Operating Officer | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
BLUEPRINT MEDICINES CORPORATION | Health Technology |
XILIO THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Eidetica Biopharma GmbH
Eidetica Biopharma GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Eidetica Biopharma GmbH is a Swiss company that develops and manufactures biopharmaceutical drugs. The company is based in Zug, Switzerland. | Health Technology |
- Bourse
- Insiders
- Christina Rossi
- Expérience